Pharmacogenomic Determinants of Asparaginase-Induced Hypersensitivity, Pancreatitis, Thrombosis, and Hepatotoxicity in Children: A Systematic Review
Gene–drug pair / mechanism
Genetic associations with asparaginase toxicities: class II HLA alleles for hypersensitivity, PNPLA3 for hepatotoxicity
Summary
Asparaginase, used in childhood haematological malignancies, is limited by toxicities: hypersensitivity, pancreatitis, thrombosis and hepatotoxicity. This systematic review searched MEDLINE, Embase and Web of Science; forty studies met inclusion criteria, with risk of bias assessed by two reviewers (Q-GENIE tool). Evidence is strongest for hypersensitivity, with consistent replication of associations with class II HLA alleles, whose risk alleles differ by ancestry. For hepatotoxicity, only three studies were available, but PNPLA3 rs738409 was identified and independently replicated. Associations with pancreatitis and thrombosis are heterogeneous, with many candidate loci that are poorly validated in independent cohorts.
Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.
Analysis
Systematic review without meta-analysis: no pooled estimate is produced, and the heterogeneity of toxicity definitions noted by the authors would make one difficult. The two retained signals, class II HLA for hypersensitivity and PNPLA3 for hepatotoxicity, are not equivalent: the latter rests on only three studies. No test is to be offered routinely at this stage, as the authors conclude.
Analysis by Dr Thibaut Benquey
Why this score?
Clinical impact: 1/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 6/10
Keywords
Every Wednesday · Annotated selection · Free · Unsubscribe anytime